Emulsions may boost flavonoid bioavailability, suggests study
The use of flavonoids as stabilisers for oil-and-water emulsions could boost the bioavailability of the compounds, according to new research.
Archives for February 21, 2011
UK advertising watchdog to target online marketing from March 1
The UK Advertising Standards Authority (ASA) will begin monitoring online marketing materials for the first time from March 1.
Arab Revolt underlines the need for action to remedy high food prices
When Tunisian street vegetable vendor Mohamed Bouazizi chose to end his life in fiery suicide, no one could have foreseen the firestorm his death would unleash across the Arab world. But, two months later, as the Arab Revolt shows no sign of fading, the...
Lipid Nutrition withdraws Oz/NZ CLA Novel Foods application
Dutch-based Conjugated Linoleic Acid (CLA) player, Lipid Nutrition, has withdrawn its CLA Novel Foods application in Australia and New Zealand due to the two countries’ policy to reduce all trans fatty acids (TFAs) in the diet.
Probiotics documentary reaches out to health professionals
A recently completed documentary about probiotics is being welcomed by the probiotics community with Danisco, the world’s biggest probiotics supplier saying it provides an opportunity to raise awareness of the microorganisms among the medical fraternity.
Omega-3s may counter degenerative muscle loss: Study
Daily supplements of omega-3 fatty acids may boost the production of muscle protein in older people, and reduce the risk of degenerative muscle loss, suggest data from a new human trial.
DuPont extends Danisco offer deadline
DuPont has extended the tender offer period related to its acquisition of Danisco shares by more than a month to April 1, 2011, the company has said.
DSM reports successful tender offer for Martek
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...